Phase 4 N=303 Prophylactic Antimicrobial Catheter Lock
Bacteremia
Primary: Rate of Device-related Bacteremia — 30; 11 Number of infections
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=99 Greater Occipital Nerve Block Versus Metoclopramide
Migraine
Primary: 0-10 Pain Score — 5.0; 6.1 units on a scale
Phase 4 N=95 Connectivity Affecting the Antidepressant REsponse Study
Major Depressive Disorder
Primary: Number of Patients With Remission of Depression — 37; 13 Participants — p=0.0689
Phase 4 N=65 Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe
Chorioretinal Vascular Disease
Primary: Number of Aflibercept Injections Successfully Administered Utilizing the Prefilled Syringe (PFS) — 35; 29 Injections
Phase 4 N=35 Concentration-Controlled Ribavirin for the Treatment of Patients With Chronic Hepatitis C Virus Infection
Hepatitis C Virus
Primary: Ribavirin AUC-12 Variability — 34425; 40903 ng*hr/mL
Phase 4 N=30 Human Fibrinogen Concentrate in Pediatric Cardiac Surgery
Hypofibrinogenemia · Afibrinogenemia · Bleeding Disorders
Primary: Postoperative Blood Loss After Surgery (Estimated Blood Loss (EBL)) — 35; 33 cc/kg
Phase 4 N=5,260 INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
Heart Failure · Myocardial Infarction
Primary: All-Cause Death or Cardiopulmonary Hospitalization Within Each Vaccination Season — 975; 924 Participant-Seasons — p=0.21
Phase 4 N=26 Treatment of Tracheostomy Granulomas
Granuloma · Tracheostomy
Primary: Success and Failure Rates for Each Treatment Method — 6; 3; 5; 3 Participants
Phase 4 N=32 Insulin Pump to Multiple Daily Injection Transition Clinical Trial
Type 1 Diabetes
Primary: Time Spent With CGM Glucose Levels >180mg/dl Between Two Groups — 46.3; 38.5 percentage of time spent >180 mg/dL
Phase 4 N=40 Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.
Renal Angiomyolipoma
Primary: Percentage of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) — 40; 39; 6; 2 Participants
Phase 4 N=50 Dexmedetomidine for Sedation of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
Bronchoscopy
Primary: Hypoxemia During Maintenance — 8; 14 Participants
Phase 4 N=27 Belatacept 3 Month Post Transplant Conversion Study
Transplant; Failure, Kidney · EBV
Primary: Change in eGFR (MDRD) at 2 Years Post-transplant Compared to Baseline at Month 3 (Conversion) — -5.44; 8.08; -0.38 mL/min/1.73m2
Phase 4 N=10 Drug-Drug Interaction Between Rifampin and Fluvastatin
Drug-drug Interaction
Primary: AUC — 242; 642; 124; 371 ng/mL·h
Phase 4 N=118 Pain Control Following Sinus Surgery
Sinusitis · Opioid Use · Opioid Abuse
Primary: Pain Severity — 12.4; 8.5 units on a scale
Phase 4 N=47 ED90 of 3% Chloroprocaine for Cervical Cerclage
Cerclage, Cervical
Primary: The Dose of Intrathecal (IT) Chloroprocaine That Provides Effective Anesthesia in 90% of Patients Undergoing Elective Cerclage Placement (Intraoperative Analgesic…